GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?
The 2023 Nobel Prize for Physiology or Medicine will be awarded on Monday, and some prize forecasters wonder if it will go to the research behind metabolism-correcting, weight-moderating drugs like Ozempic, Wegovy, and Mounjaro. But who would be recognized? After months of reporting and interviews with dozens of researchers, STAT has identified many of the scientists who were instrumental in creating this transformative family of drugs. (STAT also recently told the story of how one of these scientists had been edged out of the spotlight.)
Read More
No comments